Stocks-Prognosis.com
Catalog Account
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

February 26, 2025
Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy. The company's strong financial performance, innovative pipeline of drugs, and commitment to research and development have positioned it well in the competitive pharmaceutical industry. Investors seeking long-term growth potential can consider adding Amgen to their portfolio. For a professional forecast of Amgen's stock movement, consult experts at Stocks Prognosis.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

Amgen's strong position in the pharmaceutical industry and their focus on innovation make them a compelling investment choice
— from MarketMegan at 03-01-2025 19:50
I believe Amgen has a promising future in the pharmaceutical sector. Their research and development efforts can lead to significant breakthroughs
— from FinanceFelix at 03-01-2025 19:49
I've been following Amgen for a while and I'm excited about their potential. Their commitment to research and development is a key factor for me
— from CharlotteCampbell at 03-01-2025 16:05
I'm confident in Amgen's ability to deliver strong financial performance and I believe their innovative pipeline will drive future growth
— from InvestorIvy at 03-01-2025 13:09
Amgen's commitment to research and development is impressive. I think they have a lot of potential for growth
— from RiskyRachel at 03-01-2025 10:52
I've been researching Amgen and I'm impressed with their financial performance. It seems like a good investment opportunity
— from KatherineSanchez at 03-01-2025 09:44
Amgen's financial performance and dedication to research and development make it an attractive investment in the pharmaceutical industry
— from FinanceFinn at 03-01-2025 02:07
I've heard good things about Amgen's innovative pipeline of drugs. I think it could be a smart investment
— from MoneyMabel at 02-28-2025 23:11
I've been keeping an eye on Amgen and I think it's a solid investment choice. Excited to see its future growth
— from PennyInvestor at 02-28-2025 10:49
Amgen's stock looks promising, especially considering their strong financial performance and innovative drug pipeline
— from SaraBrown at 02-28-2025 08:38
I'm unsure about Amgen's ability to stay ahead in the competitive pharmaceutical industry. It might be too risky for my investment portfolio
— from SavingsSandy at 02-28-2025 02:57
I'm interested in adding Amgen to my portfolio. Their strong financial performance and innovative pipeline make them an attractive investment
— from NoraJenkins at 02-27-2025 21:17
Amgen has a solid track record and their commitment to research and development sets them apart. It's definitely a stock to consider
— from JamesThomas at 02-27-2025 20:04
Amgen is a strong company with a bright future. Investing in their stock could be a smart move
— from WealthyWalter at 02-27-2025 20:01
Amgen's stock has great potential for long-term growth. It's definitely worth considering for my portfolio
— from KatherineSanchez at 02-27-2025 10:44
I agree with the analysts' assessment. Amgen's strong financials and focus on research and development make it an attractive investment in the pharmaceutical industry
— from HannahCarter at 02-27-2025 02:45
Amgen's commitment to research and development is commendable. I think they have a bright future in the pharmaceutical industry
— from SavingsSarah at 02-26-2025 18:48
I've been looking to invest in pharmaceutical stocks and Amgen seems like a great option, especially with their strong financial performance and commitment to research and development
— from CashClaire at 02-26-2025 16:16
I'm not convinced about Amgen's long-term growth potential. The pharmaceutical industry is highly competitive and there are many other options to consider
— from DividendDiane at 02-26-2025 13:12
I think Amgen is a smart investment choice. Their dedication to research and development sets them apart in the pharmaceutical industry
— from GrowthGreg at 02-26-2025 12:27
While Amgen seems interesting, I'm concerned about the volatility of the pharmaceutical industry. I'll need to do more research before considering it
— from TylerGonzalez at 02-26-2025 05:13
If you want to leave a comment, then you need Login or Register





Other news for AMGN

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....



Related news

AMGNNovember 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN  ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

AMGNDecember 18, 2024Amgen Inc. Reports Impressive Returns Over Last Three Years  ~1 min.

Amgen Inc. (NASDAQ:AMGN) has proven to be a solid investment option, with investors enjoying a favorable 34% return over the past three years....

AMGNJanuary 11, 2025Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership  ~1 min.

Amgen Inc. (NASDAQ:AMGN) continues to attract the attention of institutional investors, with a significant 78% ownership held by these financial giants....

AMGNFebruary 3, 2025Amgen Inc. Continues to Impress with Strong Quarterly Earnings  ~1 min.

Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company, once again surpassed expectations with its impressive quarterly earnings report....

AMGNDecember 28, 2024Amgen Inc.'s Stock Shows Promising Gains: Here's the Latest Update  ~2 min.

Investors are eagerly searching for information on Amgen Inc. (NASDAQ:AMGN) as the company's stock gains momentum in the market....



Stocks-Prognosis.com © 2025

All rights reserved. MERTANA CORP.
With from New York

A unique system for forecasting the movement dynamics of stocks and securities uses advanced algorithms and analytical methods to accurately predict market changes. It enables investors to make timely decisions, optimize their portfolios, and minimize risks, ensuring steady growth and high returns in an ever-changing financial landscape